bioMérieux - 2014 Financial Results
Solid growth in sales:
- Up 8.7%, including BioFire and at constant exchange rates
- Up 3.8%, at constant exchange rates and scope of consolidation
Contributive operating income before non-recurring items*: €227 million, in line with the objective set at the beginning of the year
Sustained successful sales performance by BioFire and FilmArray® in molecular biology
Significant strategic and operating advances, with the signature of eight business development agreements
Higher contributive operating income before non-recurring items* expected in 2015, while the Company continues its efforts in sales & marketing, production and innovation, as well as its priority action plans to sustainably strengthen operating performance.